Prime Medicine, Inc. (PRME) stock
Close on Nov 13, 2026Market cap $774.48MP/E –Yield –
Prime Medicine statistics
64 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Mar 2, 2027 (estimated, before the open)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 91.80
- 2.22
Share statisticsIndustry
- Shares Change (YoY)
- 28.6%
- 10.8%
- Shares Change (QoQ)
- 0.36%
- 0.50%
- Float
- 148M
- 49M
- Shares Held by Insiders
- 18.6%
- 11.7%
- Shares Held by Institutions
- 58.8%
- 56.4%
Short sellingIndustry
- Short Interest
- 29M
- –
- Short Interest Change
- -11.3%
- -0.80%
- Short % of Float
- 19.7%
- 9.01%
- Short % of Shares Outstanding
- 16.1%
- 6.30%
- Days to Cover
- 4.80
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $5.91
- –
- 52-Week Low
- $2.67
- –
- 20-Day Moving Average
- $4.30
- –
- 50-Day Moving Average
- $3.70
- –
- 200-Day Moving Average
- $3.50
- –
- Average True Range (14)
- $0.49
- –
- Price Change (1 Week)
- -8.17%
- -1.15%
- Price Change (1 Month)
- 18.3%
- -4.87%
- Price Change (3 Months)
- 34.7%
- -21.0%
- Price Change (6 Months)
- 45.7%
- -20.6%
- Price Change (YTD)
- 23.1%
- -23.6%
- Price Change (1 Year)
- 20.3%
- -22.4%
- Price Change (3 Years)
- -39.6%
- -29.5%
- Price Change (10 Years)
- -77.6%
- -65.4%
- Average Volume (10 Days)
- 5M
- –
- Average Volume (20 Days)
- 6M
- –
- Average Volume (90 Days)
- 4M
- –
- Relative Volume
- 1.48
- 0.70
- Relative Strength Index (14)
- 51.9
- 43.4
- Volatility (1 Year)
- 92.6%
- 80.1%
- Beta (5 Years)
- 2.05
- 1.07
Returns on capitalIndustry
- Return on Equity (ROE)
- -207.2%
- -49.9%
- Return on Assets (ROA)
- -58.9%
- -40.6%
- Return on Capital Employed (ROCE)
- -102.4%
- -37.9%
Financial positionIndustry
- Current Ratio
- 1.79
- 3.30
- Quick Ratio
- 1.72
- 2.39
GrowthIndustry
- Revenue Growth (5Y CAGR)
- -2.32%
- 6.41%
EfficiencyIndustry
- Profits Per Employee
- -$1.21M
- -$689.41K
- Employee Count
- 146
- 74
- WACC
- 15.4%
- 10.2%
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $61.20M
- $17.76M
- Net Cash Per Share
- $0.34
- $0.80
- Equity (Book Value)
- $8.44M
- $53.89M
- Book Value Per Share
- $0.05
- $1.50
- Tangible Book Value
- $8.44M
- $27.13M
- Working Capital
- $28.06M
- $79.99M
Cash flow (TTM)Industry
- Capital Expenditures
- -$848.00K
- -$1.00M
- FCF Per Share
- -$0.87
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -22.8%
- -21.8%
- FCF Yield
- -20.5%
- -9.44%
Scores and fair valueIndustry
- Altman Z-Score
- -7.06
- 0.23
- Piotroski F-Score
- 4
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | PRME | S&P 500 | Difference | PRME per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +28.6% | -3.0% | +31.7 pts | ||
| 3 months | +34.7% | -2.8% | +37.5 pts | ||
| Year to date | +23.1% | +11.5% | +11.6 pts | ||
| 1 year | +28.2% | +13.5% | +14.8 pts | ||
| 3 years | -35.9% | +77.7% | −113.6 pts | -13.8% | +21.1% |
| 5 years | -78.9% | +72.6% | −151.5 pts | -26.7% | +11.5% |
| 10 years | -77.9% | +308.2% | −386.1 pts | -14.0% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
29M PRME shares were sold short on Oct 30, 2026, down 11.3% from the previous report, or 19.74% of the shares available to trade. At recent volumes it would take 4.8 days to buy them back. Over the last 20 sessions, 47.2% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 29,147,049 | -11.3% | 6,070,767 | 4.8 |
| Oct 15, 2026 | 32,871,532 | +2.4% | 5,957,204 | 5.5 |
| Sep 30, 2026 | 32,116,376 | -0.0% | 3,802,941 | 8.4 |
| Sep 15, 2026 | 32,132,218 | -12.6% | 2,610,870 | 12.3 |
| Aug 31, 2026 | 36,761,940 | +5.0% | 2,798,970 | 13.1 |
| Aug 14, 2026 | 35,022,290 | +0.1% | 2,533,307 | 13.8 |
| Jul 31, 2026 | 35,003,578 | +4.4% | 2,714,294 | 12.9 |
| Jul 15, 2026 | 33,536,516 | -3.4% | 4,978,508 | 6.7 |
| Jun 30, 2026 | 34,729,797 | +6.7% | 3,810,751 | 9.1 |
| Jun 15, 2026 | 32,533,956 | +5.6% | 2,883,767 | 11.3 |
| May 29, 2026 | 30,820,036 | +1.0% | 2,749,345 | 11.2 |
| May 15, 2026 | 30,528,072 | +0.6% | 2,601,566 | 11.7 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?